Ismaila AS, Rothnie KJ, Wood RP, et al.

Title: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Citation: Respir Res
2023;24:229.*

Country: UK | Indication: COPD

This is a GSK-supported study

http://tago.ca/37749551
* Access the erratum (Ismaila AS, et al. Respir Res 2024;25:152) here: https://pubmed.ncbi.nlm.nih.gov/38561735/
* Access the erratum (Ismaila AS, et al. Respir Res 2024;25:152) here: https://pubmed.ncbi.nlm.nih.gov/38561735/
Scan to access the publication or visit
http://tago.ca/37749551